DK1105390T3 - Imidazo(1,2a)pyridinderivater til behandling af gastrointestinale sygdomme - Google Patents

Imidazo(1,2a)pyridinderivater til behandling af gastrointestinale sygdomme

Info

Publication number
DK1105390T3
DK1105390T3 DK99944965T DK99944965T DK1105390T3 DK 1105390 T3 DK1105390 T3 DK 1105390T3 DK 99944965 T DK99944965 T DK 99944965T DK 99944965 T DK99944965 T DK 99944965T DK 1105390 T3 DK1105390 T3 DK 1105390T3
Authority
DK
Denmark
Prior art keywords
imidazo
treatment
gastrointestinal disorders
pyridine derivatives
pyridine
Prior art date
Application number
DK99944965T
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1105390T3 publication Critical patent/DK1105390T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99944965T 1998-08-21 1999-08-18 Imidazo(1,2a)pyridinderivater til behandling af gastrointestinale sygdomme DK1105390T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802793A SE9802793D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001401 WO2000010999A2 (en) 1998-08-21 1999-08-18 New compounds

Publications (1)

Publication Number Publication Date
DK1105390T3 true DK1105390T3 (da) 2003-09-22

Family

ID=20412306

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99944965T DK1105390T3 (da) 1998-08-21 1999-08-18 Imidazo(1,2a)pyridinderivater til behandling af gastrointestinale sygdomme

Country Status (22)

Country Link
US (1) US6613775B1 (da)
EP (1) EP1105390B1 (da)
JP (1) JP2002523414A (da)
KR (1) KR20010072797A (da)
CN (1) CN1161355C (da)
AR (1) AR020225A1 (da)
AT (1) ATE242242T1 (da)
AU (1) AU770511B2 (da)
BR (1) BR9913102A (da)
CA (1) CA2339372A1 (da)
DE (1) DE69908608T2 (da)
DK (1) DK1105390T3 (da)
ES (1) ES2201769T3 (da)
HK (1) HK1036274A1 (da)
IL (1) IL141165A0 (da)
MY (1) MY121387A (da)
NO (1) NO20010861L (da)
NZ (1) NZ509744A (da)
PT (1) PT1105390E (da)
SE (1) SE9802793D0 (da)
WO (1) WO2000010999A2 (da)
ZA (1) ZA200100911B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ATE447555T1 (de) 2003-03-10 2009-11-15 Nycomed Gmbh Neues verfahren zur herstellung vonroflumilast
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005026164A1 (en) * 2003-09-18 2005-03-24 Altana Pharma Ag Pharmacologically active imidazo[4,5-c]pyridines
KR20060099524A (ko) 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2575345A1 (en) * 2004-08-02 2006-02-09 Altana Pharma Ag 5-substituted 1h-pyrrolo[3,2-b]pyridines
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
EP2258350B1 (en) 2005-03-16 2014-12-24 Takeda GmbH Taste masked dosage form containing roflumilast
WO2006100119A1 (en) * 2005-03-24 2006-09-28 Glaxo Group Limited Derivatives of imidazo (1,2-a) pyridine useful as medicaments for treating gastrointestinal diseases
EP2641906B1 (en) 2009-07-08 2015-04-22 Dermira (Canada), Inc. Tofa analogs useful in treating dermatological disorders or conditions
BRPI1013288A2 (pt) 2009-07-09 2016-03-29 Raqualia Pharma Inc uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers

Also Published As

Publication number Publication date
CN1323308A (zh) 2001-11-21
IL141165A0 (en) 2002-11-10
NO20010861L (no) 2001-04-10
WO2000010999A2 (en) 2000-03-02
DE69908608D1 (de) 2003-07-10
WO2000010999A3 (en) 2000-06-02
HK1036274A1 (en) 2001-12-28
DE69908608T2 (de) 2004-04-29
SE9802793D0 (sv) 1998-08-21
AR020225A1 (es) 2002-05-02
EP1105390B1 (en) 2003-06-04
NZ509744A (en) 2003-05-30
AU770511B2 (en) 2004-02-26
NO20010861D0 (no) 2001-02-20
ES2201769T3 (es) 2004-03-16
PT1105390E (pt) 2003-10-31
BR9913102A (pt) 2001-05-08
US6613775B1 (en) 2003-09-02
CA2339372A1 (en) 2000-03-02
AU5767899A (en) 2000-03-14
JP2002523414A (ja) 2002-07-30
ATE242242T1 (de) 2003-06-15
KR20010072797A (ko) 2001-07-31
ZA200100911B (en) 2002-05-02
MY121387A (en) 2006-01-28
CN1161355C (zh) 2004-08-11
EP1105390A2 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
PT1218378E (pt) Derivados de terc-butil-(7-metil-imidazo-¬1,2-a|-piridin-3-il)-amina
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
NO20012160D0 (no) Anordning for behandling av makulös degenerering
ATE214704T1 (de) 5h-thiazolo(3,2-a)pyrimidinderivate
DK1105390T3 (da) Imidazo(1,2a)pyridinderivater til behandling af gastrointestinale sygdomme
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
IS5952A (is) Aðferð til framleiðslu á 5-sýanóþalíði
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK199800837A (da) Anlæg til behandling af emner
ATE204279T1 (de) Diaza-spiro(3,5)nonan-derivate
DK0983275T3 (da) Nye triptolidderivater, der er nyttige til behandling af autoimmune sygdomme
NO20010456L (no) Triazolopyridiner for behandling av trombose lidelser
ATE270294T1 (de) 1,2,3,4-tetrahydro-benzofuro(3,2-c)pyridin derivate
DK0935598T3 (da) 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet
DK1121356T3 (da) 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser
NO20012461L (no) Krystallmodifikasjon B av 8-cyano-1-cyklopropyl-7-(1S,6S-2,8- diazabicyklo(4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre
DK0735043T3 (da) Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
DK1075473T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
IS6098A (is) Ósantant til meðhöndlunar á skaptruflunum
DK1413575T3 (da) Fremgangsmåde til fremstilling af derivater af (1,5-diaryl)pyrazol-3-ylpropansyre
IS2153B (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
NO20005743D0 (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- oksyglukoronider
DK1175420T3 (da) Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater